Status:
UNKNOWN
Clinico-biological Collection of Subjects With Hyper Lipoprotein a in Reunion Island
Lead Sponsor:
Centre Hospitalier Universitaire de la Réunion
Conditions:
Cardiovascular Disease
Eligibility:
All Genders
Phase:
NA
Brief Summary
Cardiovascular disease (CVD) is the second leading cause of death in France and the leading cause of death on Reunion Island. Some modifiable risk factors for cardiovascular diseases are well identifi...
Eligibility Criteria
Inclusion
- Patient with Lp (a)\> 200 nmol / L OR member of family of a patient with Lp (a)\> 200 nmol / L
- be affiliated or beneficiary of a social security scheme
- signed consent
Exclusion
- Refusal to participate
Key Trial Info
Start Date :
September 19 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2023
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04310917
Start Date
September 19 2020
End Date
June 1 2023
Last Update
August 30 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre Hospitalier Universitaire de la Réunion
Saint-Denis, France, 97400